This inventor holds 1 USPTO granted patent. Top assignee: Aptose Biosciences Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Santosh Kumar Kotturi Rajaiah: Innovator in Pharmaceutical Compounds
Introduction
Santosh Kumar Kotturi Rajaiah is a notable inventor based in Secunderabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical pathways in disease treatment.
Latest Patents
Santosh holds a patent for "Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof." This invention focuses on fused pyrimidine compounds, specifically pyrrolopyrimidine and thienopyrimidine compounds and their derivatives. The patent outlines pharmaceutical compositions and methods for inhibiting BRD4 and/or JAK2, which are essential in treating various diseases, including cancer and leukemia.
Career Highlights
He is currently associated with Aptose Biosciences Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His research and inventions have the potential to impact the treatment landscape for serious health conditions.
Collaborations
Santosh collaborates with esteemed colleagues such as Ram Shankar Upadhayaya and Raghava Reddy Kethiri, contributing to a dynamic research environment that fosters innovation.
Conclusion
Santosh Kumar Kotturi Rajaiah exemplifies the spirit of innovation in the pharmaceutical sector, with his work paving the way for new treatment options for critical diseases. His contributions are a testament to the importance of research and development in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile